FindTrial
Sign In

"Needle free injection-electrocoagulation hemostasis" sequential treatment strategies in ESD intraoperative bleeding hemostatic application randomized controlled study

"Needle free injection-electrocoagulation hemostasis" sequential treatment strategies in ESD intraoperative bleeding hemostatic application randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075851
Enrollment
Unknown
Registered
2023-09-18
Start date
2023-09-18
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early cancer or precancer of the upper digestive tract requiring endoscopic submucosal dissection

Interventions

experimental group:the sequential treatment of "Needle free injection-electrocoagulation hemostasis"
control group:Traditional electrocoagulation therapy

Sponsors

Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age =18 years old, gender is not limited; (2) Early cancers or precancerous lesions of the upper digestive tract requiring endoscopic submucosal dissection; (3) Patients who voluntarily accept and abide by this experimental protocol, receive review and follow-up on time, and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Pregnant women; (2) complicated with gastrointestinal varices or hemangioma; (3) severe anemia and coagulation disorders (Hb 2; PT (prothrombin time) was 10 seconds longer than the standard value; (4) patients with definite preoperative diagnosis of hypertension (systolic blood pressure >140mmHg or/and diastolic blood pressure >90mmHg); (5) participants enrolled in other clinical trials 3 months before surgery or during the trial; (6) Unable to tolerate endoscopic submucosal dissection due to poor cardiopulmonary function and other factors.

Design outcomes

Primary

MeasureTime frame
Hemostatic related injuries to the muscularis propria during ESD;Hemostasis related perforation occurred during and after ESD;ESD intraoperative bleeding hemostatic time every time;—

Secondary

MeasureTime frame
Clarity of bleeding points;Number of hemostasis exchange instruments (hemostatic forceps) per ESD procedure;Number of clips used for active bleeding per ESD procedure (excluding clips used to prevent bleeding and perforation);The number of electrocoagulation hemostasis in each ESD operation;The percentage of ESD hemostasis time in total operation time;—

Countries

China

Contacts

Public ContactChaoqiang Fan

Second Affiliated Hospital of Army Medical University

fcqxhkwjs@126.com+86 159 2278 1214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026